I was looking for information tonight about the new Senseonics Eversense iCGMS. I found one interesting article in which the company goes on record as saying they think they’ll have better luck with reimbursement because people are almost guaranteed to use it, and that’s what payers really care about. But this post isn’t really about Senseonics. It’s about CGMS usage in general and this statistic imparticular:
"Senseonics VP and GM of the U.S. Region Mike Gill told BioWorld MedTech . ‘People don’t use their CGM all the time. We see in clinical studies, they use it about 80 percent of the time, and they have great results: lower HbA1c, lower hypoglycemia. But when they come out of those clinical studies, they actually drop to using it 60 percent of the time, and payers know that.’
‘Plus, they can see it in the claims data,’ he continued. ‘They know that someone’s not ordering sensors all the time.’"
I find this interesting. Everyone I know online and in real life with a CGM uses it very close to 24/7. The closest I come to a break is maybe a few hours in between sensors. That’s it.
When I used a Medtronic CGM I did not use it often because it wasn’t accurate. When I did use it my control was probably a little better but not from the sensor- from all the finger sticks I was doing to check how far off the sensor was.
I wonder if some of their usage data is skewed from people restarting sensors? I would think insurance companies would like that. Heck, I would think insurance companies would like people not reordering sensors for any reason.
So, is anyone here a part time CGMS user?